Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp
Status:
RECRUITING
Trial end date:
2026-09-30
Target enrollment:
Participant gender:
Summary
A Phase 3 clinical trial of oral GnRH antagonist pre-treatment for women with endometriosis who are undergoing IVF, with a primary outcome of live birth rate. The investigators' central hypothesis is that in infertile woman with endometriosis undergoing in vitro fertilization-embryo transfer (IVF-ET), live birth rates will improve in those pretreated with GnRH antagonist compared to those not pretreated with GnRH antagonist.
Phase:
PHASE3
Details
Lead Sponsor:
Yale University
Collaborators:
Duke University Johns Hopkins University Northwestern University University of Colorado, Denver University of North Carolina